CompletedPhase 4

LEAF - Low Energy In Atrial Fibrillation

237 participantsStarted 2000-08

Plain-language summary

The purpose of the study is to demonstrate the efficiency on AT / AF prevention and termination of a new algorithm contained in the Medtronic AT500 Antitachycardia device in patients with conventional pacemaker indications.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ACC/AHA Class I or II indication for dual chamber pacing and two symptomatic atrial fibrillation or flutter episodes in the three months prior to implant as well as ECG documentation of at least one episode in the prior year. Exclusion Criteria: * Patients with permanent/persistent AF, an indication for an implantable cardioverter defibrillator or class IV heart failure.

What they're measuring

Demonstrate that AT 500 algorithms decrease AF Burden

Trial details

NCT IDNCT00157781

SponsorMedtronic Cardiac Rhythm and Heart Failure

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Atrial Fibrillation trials